The present invention relates to a novel improved protein mutant which produces low allergenic response in humans compared to the parent of that mutant. Specifically, the present invention comprises neutralizing or reducing the ability of T-cells to recognize epitopes and thus prevent sensitization of an individual to the protein.

La actual invención se relaciona con un mutante mejorado novela de la proteína que produzca respuesta alergénica baja en los seres humanos comparados al padre de ese mutante. Específicamente, la actual invención abarca neutralizar o la reducción de la capacidad de T-ce'lulas de reconocer epitopes y de prevenir así la sensibilización de un individuo a la proteína.

 
Web www.patentalert.com

< (none)

< Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a .beta.-C-4-oxygenase activity for biotechnological production of (3S, 3'S) astaxanthin and its specific expression in chromoplasts of higher plants

> Method of obtaining haemin from slaughter blood

> (none)

~ 00006